Galmed Archives | GeoInvesting

Galmed

SanaCurrents BioTech Research Service Inaugural Reports on EIDX and GLMD
Gallery
SanaCurrents BioTech Research Service Inaugural Reports on EIDX and GLMD

Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology

SanaCurrents BioTech Research Service Inaugural Reports on EIDX and GLMD

By Bill Langbein|2020-03-11T15:33:54-04:00November 18th, 2018|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: Bill Langbein, Eidos Therapeutics, EIDX, Galmed, GLMD, healthcare, SanaCurrents|

Last week, Galmed Pharmaceuticals (NASDAQ:GLMD) shares climbed as high as [...]

0

Galmed (GLMD) – November Catalyst: Aramchol
Gallery
Galmed (GLMD) – November Catalyst: Aramchol

Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment

Galmed (GLMD) – November Catalyst: Aramchol

By Bill Langbein|2019-01-22T10:04:09-05:00November 6th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: Bill Langbein, Galmed, GLMD, healthcare, SanaCurrents|

November Catalyst: Aramchol SanaCurrents forecasts an advantageous probability Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) [...]

0